Journal Article Summary

The article investigates the long-term management of recurrent otitis externa (RO) in dogs, a condition often linked to allergic skin diseases that can lead to repeated infections. This topic is significant because RO can be challenging to treat, causing discomfort for dogs and frustration for their owners. The study aims to evaluate a two-phase treatment protocol that combines an initial stabilization phase with a specific ear drop solution followed by a proactive maintenance phase using a topical corticosteroid to prevent recurrences.

In the study, 45 dogs with a history of bilateral RO were treated in two phases. The first phase involved administering a combination of ciprofloxacin, clotrimazole, and betamethasone to reduce bacterial infections, while the second phase used hydrocortisone aceponate to maintain ear health. Results showed that while the initial treatment reduced bacterial infections, it led to an increase in yeast infections. However, during the proactive phase, most dogs experienced significant improvement, with a marked reduction in clinical signs and no recurrence of otitis.

Despite the positive outcomes, the study has limitations, including the lack of a placebo group and the absence of long-term monitoring beyond one year. Readers should discuss these findings with their veterinarians, especially regarding the potential for yeast overgrowth and the importance of tailored treatment plans for their pets. It is crucial to consider the safety profile of hydrocortisone aceponate and its role in managing RO effectively while minimizing side effects.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Ramos Fernanda Oliveira, Filgueiras R., Teixeira M. A., Melo L. H. A., Araújo M. R. F., Morgado A. L. F., Lira G. A., Gomes M. E. N., et al.. Long-term management of recurrent otitis externa in dogs using a two-phase protocol involving ciprofloxacin-clotrimazole-betamethasone and topical hydrocortisone aceponate. BMC Veterinary Research 2026. DOI: 10.1186/s12917-025-05200-1. PMID: 41501900. PMCID: PMC12908394.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]